St. Jude Medical, Inc. (NYSE:STJ) today announced European CE Mark approval of two integrated components: the Cool Point(TM) Irrigation Pump and the IBI-1500T11 Cardiac Ablation Generator. Designed to enhance physicians’ ability to perform successful cardiac ablations, the integrated components were developed for use together with the St. Jude Medical family of Therapy(TM) Cool Path(TM) irrigated catheters. Catheter ablation therapy is used by physicians to restore a normal heart rhythm in patients with arrhythmias, including atrial and ventricular arrhythmias. During cardiac ablation, an electrophysiologist uses a catheter (a thin, flexible tube) to deliver radiofrequency (RF) energy to create lesions in specific areas of cardiac tissue. The lesions, or tiny scars, interrupt the abnormal electrical signals that contribute to erratic heart rhythms.
